Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 27, Issue 10, Pages 1953-1958
Publisher
Springer Nature
Online
2013-03-07
DOI
10.1038/leu.2013.74
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial
- (2013) H. Gisslinger et al. BLOOD
- Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: An international study of 264 patients
- (2012) Veronika Buxhofer-Ausch et al. AMERICAN JOURNAL OF HEMATOLOGY
- Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort
- (2012) P. J. Campbell et al. BLOOD
- Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)
- (2012) T. Barbui et al. BLOOD
- Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up
- (2012) Elisabeth Ejerblad et al. Hematology
- The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis
- (2012) Umberto Gianelli et al. MODERN PATHOLOGY
- Evidence that Prefibrotic Myelofibrosis Is Aligned along a Clinical and Biological Continuum Featuring Primary Myelofibrosis
- (2012) Giovanni Barosi et al. PLoS One
- Reproducibility of Histologic Classification in Nonfibrotic Myeloproliferative Neoplasia
- (2011) Suzanne M. Koopmans et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
- (2011) J. Thiele et al. BLOOD
- Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
- (2011) A. Carobbio et al. BLOOD
- European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis
- (2011) T. Buhr et al. HAEMATOLOGICA
- Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
- (2011) G Finazzi et al. LEUKEMIA
- How I treat essential thrombocythemia
- (2010) P. A. Beer et al. BLOOD
- Guideline for investigation and management of adults and children presenting with a thrombocytosis
- (2010) Claire N. Harrison et al. BRITISH JOURNAL OF HAEMATOLOGY
- The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera
- (2010) Khadija Abdulkarim et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis
- (2010) Maud Brousseau et al. HISTOPATHOLOGY
- Aspirin in low-risk essential thrombocythemia, not so simple after all?
- (2010) Claire Harrison et al. LEUKEMIA RESEARCH
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- JAK2V617F allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis
- (2009) Kais Hussein et al. EXPERIMENTAL HEMATOLOGY
- Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia
- (2008) A. Carobbio et al. BLOOD
- The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal
- (2008) J. L. Spivak et al. BLOOD
- Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
- (2008) F. Passamonti et al. HAEMATOLOGICA
- The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms
- (2008) Cristina A. Smith et al. HUMAN PATHOLOGY
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal
- (2008) A M Vannucchi et al. LEUKEMIA
- The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis
- (2008) Juergen Thiele et al. Current Hematologic Malignancy Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started